# Comparing Budesonide Via MAD or INSI Prospective Cohort Study

> **NCT04267042** · EARLY_PHASE1 · UNKNOWN · sponsor: **St. Paul's Hospital, Canada** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps
- Allergic Fungal Sinusitis

## Interventions

- **DRUG:** Budesonide
- **DEVICE:** Mucosal Atomization Device
- **DEVICE:** NeilMed squeeze bottle for Impregnated Nasal Saline Irrigation

## Key facts

- **NCT ID:** NCT04267042
- **Lead sponsor:** St. Paul's Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-03
- **Primary completion:** 2021-02-03
- **Final completion:** 2021-02-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04267042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04267042, "Comparing Budesonide Via MAD or INSI Prospective Cohort Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04267042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*